Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): A potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery

MLA

John E. Macor, et al. “Discovery of (R)-N-(3-(7-Methyl-1H-Indazol-5-Yl)-1-(4-(1-Methylpiperidin-4-Yl)-1-Oxopropan-2-Yl)-4-(2-Oxo-1,2-Dihydroquinolin-3-Yl)Piperidine-1-Carboxamide (BMS-742413): A Potent Human CGRP Antagonist with Superior Safety Profile for the Treatment of Migraine through Intranasal Delivery.” Bioorganic & Medicinal Chemistry Letters, vol. 23, June 2013, pp. 3157–61. EBSCOhost, https://doi.org/10.1016/j.bmcl.2013.04.012.

APA

John E. Macor, Chaturvedula Prasad, Rex Denton, Gene M. Dubowchik, Paul Moench, Valerie J. Whiterock, Charlie M. Conway, Cen Xu, Neil Mathias, Glenn H. Cantor, Robert Macci, Richard Schartman, Laura J. Signor, Stephen E. Mercer, George Thalody, Carl D. Davis, Deborah Keavy, & Sokhom S. Pin. (2013). Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): A potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery. Bioorganic & Medicinal Chemistry Letters, 23, 3157–3161. https://doi.org/10.1016/j.bmcl.2013.04.012

Chicago

John E. Macor, Chaturvedula Prasad, Rex Denton, Gene M. Dubowchik, Paul Moench, Valerie J. Whiterock, Charlie M. Conway, et al. 2013. “Discovery of (R)-N-(3-(7-Methyl-1H-Indazol-5-Yl)-1-(4-(1-Methylpiperidin-4-Yl)-1-Oxopropan-2-Yl)-4-(2-Oxo-1,2-Dihydroquinolin-3-Yl)Piperidine-1-Carboxamide (BMS-742413): A Potent Human CGRP Antagonist with Superior Safety Profile for the Treatment of Migraine through Intranasal Delivery.” Bioorganic & Medicinal Chemistry Letters 23 (June): 3157–61. doi:10.1016/j.bmcl.2013.04.012.